Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japan price cuts loom less

This article was originally published in The Gray Sheet

Executive Summary

AdvaMed is "cautiously optimistic" that upcoming biannual cuts in reimbursement for medical devices in Japan will be in aggregate less severe than in the past, the trade group's CEO Steve Ubl said. Japan's MHLW has already released its proposal to manufacturers, who have the opportunity to raise objections. The final reimbursement levels, which take effect April 1, are expected to be released shortly. The device industry continues to lobby against Japan's use of foreign average pricing and other measures to reduce device payments (1"The Gray Sheet" Oct. 8, 2007, p. 3)

You may also be interested in...



Japan’s Device Payments Will Continue To Decline, Government Official Says

Pressures on reimbursement in Japan will not ease anytime soon and more payment cuts for medical devices are expected in 2008, according to a top Japanese health official

Long Hot Summer For Novel Drug Reviews Forecast At US FDA

Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.

Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza

The latest drug development news and highlights from our US FDA Performance Tracker.

UsernamePublicRestriction

Register

MT025811

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel